PDL BioPharma (PDLI) Reports Q3 EPS of $0.18
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q3 EPS of $0.18, versus $0.14 reported last year. Revenue for the quarter came in at $67.9 million versus $62.75 million last year.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
